FDA approves injectable multiple sclerosis drug, Lemtrada

November 15, 2014 2:22 PM

10 0

An injectable multiple sclerosis drug developed by Cambridge Biotech Genzyme has been approved by the Federal regulators - FDA. It had been initially rejected ten months ago. Last night, Genzyme announced the approval of Lemtrada, used for treatment of patients with relapsing forms of debilitation disease.

"Today's approval is the culmination of more than a decade of work by Genzyme to develop Lemtrada. A comprehensive risk evaluation and mitigation strategy will be instituted in order to help detect and manage the serious risks identified with treatment" said Genzyme President and CEO David Mekeer in...

Also read: FDA approves expanded use of AstraZeneca cancer drug

Read more

To category page